Herpes labialis, also known as cold sores, is a type of infection by the herpes simplex virus that affects primarily the lip. Symptoms typically include a burning pain followed by small blisters or sores. The first attack may also be accompanied by fever, sore throat, and enlarged lymph nodes. The rash usually heals within 10 days, but the virus remains dormant in the facial nerve. The virus may periodically reactivate to create another outbreak of sores in the mouth or lip.
With over 35% value share, North America stood the top market for herpes labialis treatment in 2017. This region is expected to continue its dominance through the forecast period, followed by Western Europe, which recorded over 20% share of the total market value in 2017.
The global Herpes Labialis Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Herpes Labialis Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Herpes Labialis Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Herpes Labialis Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Herpes Labialis Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Teva
Abbott
Sun
Mylan
Pfizer
GlaxoSmithKline
Dr. Reddy's
Novartis
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Acyclovir
Valacyclovir
Famciclovir
Penciclovir
Docosanol
Segment by Application
Topical
Oral
Table of Contents
Executive Summary
1 Industry Overview of Herpes Labialis Treatment
1.1 Definition of Herpes Labialis Treatment
1.2 Herpes Labialis Treatment Segment by Type
1.2.1 Global Herpes Labialis Treatment Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Acyclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.2.5 Penciclovir
1.2.6 Docosanol
1.3 Herpes Labialis Treatment Segment by Applications
1.3.1 Global Herpes Labialis Treatment Consumption Comparison by Applications (2014-2025)
1.3.2 Topical
1.3.3 Oral
1.4 Global Herpes Labialis Treatment Overall Market
1.4.1 Global Herpes Labialis Treatment Revenue (2014-2025)
1.4.2 Global Herpes Labialis Treatment Production (2014-2025)
1.4.3 North America Herpes Labialis Treatment Status and Prospect (2014-2025)
1.4.4 Europe Herpes Labialis Treatment Status and Prospect (2014-2025)
1.4.5 China Herpes Labialis Treatment Status and Prospect (2014-2025)
1.4.6 Japan Herpes Labialis Treatment Status and Prospect (2014-2025)
1.4.7 Southeast Asia Herpes Labialis Treatment Status and Prospect (2014-2025)
1.4.8 India Herpes Labialis Treatment Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Herpes Labialis Treatment
2.3 Manufacturing Process Analysis of Herpes Labialis Treatment
2.4 Industry Chain Structure of Herpes Labialis Treatment
3 Development and Manufacturing Plants Analysis of Herpes Labialis Treatment
3.1 Capacity and Commercial Production Date
3.2 Global Herpes Labialis Treatment Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Herpes Labialis Treatment
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Herpes Labialis Treatment Production and Capacity Analysis
Summary: Get latest Market Research Reports on Herpes Labialis Treatment. Industry analysis & Market Report on Herpes Labialis Treatment is a syndicated market report, published as Global Herpes Labialis Treatment Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Herpes Labialis Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.